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Abstract
Chronic myeloid leukemia (CML) is a hematological malignancy that arises due to
reciprocal translocation of 3 sequences from c-Abelson (abl) protooncogene on chromo-
some 9 with 5 sequence of truncated break point cluster region (bcr) to chromosome 22.
The fusion gene product BCR-ABL, a functional oncoprotein p210, is a constitutively
activated tyrosine kinase that activates several cell proliferative signaling pathways.
BCR-ABL-specific tyrosine kinase inhibitors (TKIs) such as imatinib, nilotinib and
ponatinib potently inhibit CML progression. However, drug resistance owing to BCR-
ABL mutations and overexpression is still an issue. Natural products are chemical
compounds or substances produced by living organisms. They are becoming an impor-
tant research area for cancer drug discovery due to their low toxicity and cost-effective-
ness. Several lines of evidence show that many NPs such as alkaloids, flavonoids,
terpenoids, polyketides, lignans and saponins inhibit CML cell proliferation and induce
apoptosis. NPs not only differentiate CML cells into monocyte/erythroid lineage but
also can reverse the multi-drug resistance (MDR) in CML cells. In this chapter, we
review the anti-CML activity of various NPs.
Keywords: chronic myeloid leukemia (CML), BCR-ABL, TKIs, natural products (NPs),
multi-drug resistance (MDR)
1. Chronic myeloid leukemia
Chronic myeloid leukemia (CML) is a hematoproliferative neoplasm that is marked by
uncontrolled myeloid cell divisions in the bone marrow [1]. CML arises due to a reciprocal
translocation between chromosome 9 and chromosome 22 [(9;22) (q34;q11)], eventually culmi-
nating in the genesis of the bcr-abl oncogene. Approximately 90% of CML patients have
shortened chromosome called Philadelphia chromosome (Ph) [2].
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The bcr-abl oncogene encodes a constitutively activated tyrosine kinase, BCR-ABL. The cata-
lytically activated kinase, in turn, activates multiple cell proliferatory signaling pathways such
as RAS, a small GTPase, mitogen activated protein kinase (MAPK), signal transducers and
activator of transcription (STAT), and phosphoinositide-3-kinase (PI3K) pathways [3].
Targeting Abl kinase is clearly a proven successful strategy to combat CML. First generation
tyrosine kinase inhibitor (TKI), imatinib, also known as Gleevac or STI571 inhibited BCR-ABL
and suppressed CML progression [4]. Second generation TKIs such as nilotinib, dasatinib &
bosutinib and third generation TKIs (Ponatinib) that are more potent to inhibit BCR-ABL
kinase are currently used to treat CML [5, 6]. All these TKIs were approved by the US Food
and Drug Administration (FDA). TKIs have changed the clinical course of CML. However,
mutations in bcr-abl and multi-drug resistance (MDR) due to efflux of the drug as a result of
overexpression of p-glycoprotein (p-gp) make TKIs less effective. Primary or secondary resis-
tance to TKIs therapy still exists; however, there is a constant need for alternative therapeutic
strategy (Figure 1) [7].
2. Natural products
Natural products (NPs) represent a large family of diverse secondary metabolites with pro-
found biological activities. NPs are produced in several organisms like bacteria, fungi, plants
Figure 1. Schematic representation of NPs and TKIs on BCR-ABL inhibition and downregulation of downstream signal-
ing pathways (NPnatural products, TKItyrosine kinase inhibitor, CMLchronic myeloid leukemia, MDRmulti-
drug resistance).
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and marine animals. NPs are inexpensive and have less (or) no side effects; hence, NPs are
currently being explored as an invaluable source for treatment of cancerous and infectious
diseases. As of 2013, 1453 new chemical entities (NCEs) have been approved by the US FDA, of
which 40% are NPs or NP-inspired (semi-synthetic NP derivatives, synthetic compounds
based on NP pharmacophores, or NP mimics) [8, 9]. A number of NPs Such as alkaloids,
flavonoids, terpenoids, polyketides, lignans, saponins, peptides and plant extracts exhibited
potent anti-CML activity.
2.1. Alkaloids
Alkaloids are naturally occurring organic compounds containing heterocyclic ring with nitro-
gen atom. Alkaloids, widely distributed in plant kingdom, are bitter secondary metabolites
synthesized by plants, microbes and animals. They possess several physiological activities like
anti-malarial, anti-asthmatic, anti-cancer, anti-bacterial, antiviral, anti-hyperglycemic and
vasodilatory activities [1013]. Their anti-CML activity is described below.
Berbamine (BBM) is a natural bisbenzylisoquinoline product, isolated from traditional Chinese
herbal medicine Berberis amurensis, was tested on imatinib resistant K562 cell line (K562/IR)
both in vitro and in vivo. The IC50 value was found to be 17.1 and 11.1 μM at 24 and 48 h. BBM
downregulated Bcl-2, Bcl-xL, mdr-1 mRNA, p-gp levels and enhanced Bax & cytochrome C
(cyt.C) release. BALB/c or nu/nu mice were injected with K562-r subcutaneously and the
tumor-bearing mice, when treated with BBM [60 mg/kg body weight (BW)] intravenously
effectively suppressed the xenotransplated tumors in these mice [14]. BBM also induced
apoptosis in CML cells via downregulating survivin protein levels [15]. At 8 μg/ml dose of
BBM, NFκB nuclear, IKK-α, IKB-α [16], BCR-ABL, p-BCR-ABL level were decreased [17].
Furthermore, BBM-induced differentiation of CML cells into RBC, granulocyte and megakar-
yocytes [18]. Interestingly, BBM is a heat shock protein 90 (Hsp90) inhibitor [19]. BBM inhibited
MDR K562/adriamycin (ADR) [20] and K562/A02 cell lines consequently inducing apoptosis
by reducing mdr-1 gene expression and reversing MDR effect [21]. 4-chlorobenzoyl berbamine
(BBD9), an analogue of BBM was also tested against K562/IR. BBD9 with IC50 0.5 μg/ml was
found to be more effective than BBM (IC50 8 μg/ml), BBD9-lowered BCR-ABL, IKK a, nuclear
NF-κB. Furthermore, it increased the cleaved caspases 3,9, Poly(ADP-Ribose) polymerase
(PARP) and LC3-phosphatidylethanolamine conjugate (LC3 II) expression levels. In nude mice
model bearing K562 tumors, BBD9 was effective in reducing the tumor weight, promoting
tumor regression [22]. E6, a derivative of BBM, was tested against MDR K562/doxorubicin
(DOX) with 1, 3, 10 and 30 μM concentrations, and it significantly reduced the IC50 of DOX
from 79.19 μM to 35.18, 21.86, 6.31 and 1.97 μM. Co-treatment of E6 with DOX arrested K562
cells at G2/M phase [23].
Camptothecin, isolated from Camptotheca acuminate, is documented to display anti-CML activ-
ity. Homocampthothecin (hCPT), a synthetic analogue of camptothecin, showed potent activ-
ity at IC50 value of 11 nM suggesting its potential use compared to parent compound
camptothecin (IC50 57 nM) [24]. BN80927, an analogue of camptothecin, effectively inhibited
K562 cell proliferation with IC50 of 8.4 nM [25]. NSC606985, an analogue of camptothecin,
inhibited CML cell growth in a dose-dependent manner. The IC50 was found to be 6.25 nM
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[26]. Combination of imatinib and camptothecin increased Bax, cleavage of PARP-1, DNA-
dependent protein kinase (DNAPK) in CML cells [27].
Capsaicin, an active component of capsicum genus, is a homovanillic acid derivative experi-
mentally is shown to exhibit anti-mutagenic activity [28]. Capsaicin treatment of K562 cells
decreased microRNA (miRNA) expression such as miR-520a-5p, a putative target of STAT3.
Hence, capsaicin induced apoptosis via reducing mRNA involved in JNK/STAT pathway [29].
Capsaicin also stimulated GATA-1 promoter in CML cells which is an essential transcriptional
factor for the development of erythroid cells [30].
Homoharringtonine (HHT), isolated from Cephalotaxus harringtona, has been documented to
inhibit CML cell proliferation in a dose-dependent manner. The IC50 was found to be 43.89 ng/
ml. HHT arrested K562 cells at G0/G1 phase and, in addition, downregulated Bcl-2, NF-κB, p-
JAK2, p-STAT5, p-Akt, p-BCR-ABL levels [31, 32].
Sanguinarine, a benzophenanthridine alkaloid, isolated from blood root plant Sanguinaria
canadensis, belonging to the Papaveraceae family inhibited CML cell growth in a dose-depen-
dent manner. At 1.5 μg/ml, sanguinarine induced apoptosis in CML cells. At higher concen-
tration (12.5 μg/ml), sanguinarine caused blister formation in CML cells [33].
Staurosporine, an alkaloid isolated from the bacterium Streptomyces staurosporeus, not only
inhibited CML cell growth but also induced differentiation of myeloid cell lineage to megakar-
yocytic lineage resulting in polypoidy formation. Staurosporine treatment resulted in
upregulation and activation of JAK/STAT3, p-STAT3 nuclear translocation and downregulation
of c-myc [34, 35]. Staurosporine also induced differentiation of CML cells into erythroid cells
via increased CD61 and CD42b levels [36]. 7-Hydroxy staurosporine (UCN-01), a potent
PKC inhibitor is effective in inhibiting CML cell proliferation at a concentration of 3 μM for
24 h [37, 38].
Tetrandrine is a bis-benzylisoquinoline alkaloid that is isolated from Chinese herb Stephania
tetrandra. Combination of tetrandine and imatinib showed syngerisitic effect significantly
inhibited CML cell growth. The combination treatment arrested CML cells at G1/S phase,
enhanced caspase 3 mRNA, protein levels and decreased Bcl-2 mRNA, protein levels [39].
Combination of nilotinib and tetrandrine also effectively decreased the IC50 of daunorubicin
(DNR) on K562/A02 to 3.12 ± 0.13 μg/ml. This combinational effect not only increased Bax
mRNA and protein levels but also decreased the survivin mRNA and protein levels [40].
Tetrandrine citrate, a novel tetrandrine salt which is highly soluble in water, Inhibited the
growth of K562/IR, primary leukemic cells and primitive CD34 (+) leukemic cells with IC50
ranging from 1.2 to 2.97 μg/ml. Tetrandrine citrate lowered BCR-ABL mRNA and β-catenin
protein levels. Nude mice bearing CML tumors when orally administered with tetrandrine
citrate (100 mg/kg BW), reduced the tumor growth [41]. Combination of 5-bromotetrandrine
(analogue of tetrandrine) and DNR decreased p-JNK 11,2 and MDR/p-gp levels in ADR
resistant K562 cells [42].
Alkaloids from plant and microbial source inhibited CML cell proliferation in micromole (μM)/
microgram (μg) concentration (Table 1) (Figure 2) [4366]. Alkaloids are well documented to
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Alkaloid Source of isolation IC50 value
on K562 cells











Camptotheca acuminate 57 nM ↑Bax, cleavage of PARP-1,
DNAPK adducts
[24]












Stephania tetrandra  ↑Caspase 3 mRNA, protein




70% EtOH extract of
Ancistrocladus tectorius





Crude HEX, EtOAc and
AQE extracts of Pseuduvaria
rugosa (Blume) Merr
*63 and 64%  [44]
Cathachunine Catharanthus roseus (L.) G.
Don
9.3 ± 1.8 μM  [45]
Cepharanthine Stephania sp.  ↓p-gp [46]
Crebanine Stephania venosa 13 μg/ml ↓Cyclin A, D & ↑Caspases
3,9,8 & PARP and ⊥G0/G1
phase
[48]
Curine Chondrodendron platyphyllum 17.8 ± 5.2 μM  [49]
Cyanogramide Actinoalloteichus cyanogriseus
WHI-2216-6
 At 5 μM, reversed MDR in
K562/ADR
[50]




Evodia rutaecarpa 34.43 μM  [53]
Naamidine J (imidazole
containing alkaloid)
Pericharax heteroraphis 11.3 μM  [54]
Salvicine (diterpenoid
alkaloid)
Salvia prioniti 7.82 ± 2.81
μM
⊥G1 phase [56]
Solamargine (glycoalkaloid) Solanum species 5.2 μM ↑Caspases and ↓Bcl-2 [57, 58]










44 and 53 μM  [61]
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potently reduce tumor growth in in vivo models (Table 2). Besides, some alkaloids such as
capasaicin, staurosporine induces differentiation of CML cells (Table 3).
2.2. Flavonoids
Flavonoids belong to polyphenolic compounds which are prevalent in plants. They contain
two phenyl rings A, B and a heterocyclic ring C (commonly referred as C6-C3-C6 skeleton) and
are classified into many major classes like flavones, flavonols, flavanones, flavanonols and
isoflavonoids (Figure 3). They exhibit antioxidant, anti-inflammatory, anti-bacterial, antiviral
and anti-cancer activities and play a significant role in human health [6774].
Oroxylin A, an O-methylated flavone, found in the medicinal plant Scutellaria baicalensis, was
tested against MDR K562/ADR cells. Oroxylin A specifically enhanced the sensitivity of K562/
ADR to ADR by selectively inducing apoptosis. The treatment downregulated CXCR4 expres-
sion and inhibited PI3K/Akt/NF-κB pathways [75]. NOD/SCID mice-bearing K562 xenograft,
treated with oroxylin A (30 mg/kg BW) alone or in combination with imatinib enhanced the
sensitivity of imatinib to K562 cells through suppression of STAT3 pathway, decreasing p-gp
levels thus reversing MDR in CML cells [76].
Quercetin (Q), a major flavonol, found in the kingdom Plantae, exhibits many biological effects
including Antioxidant, anti-inflammatory, anti-cancer and anti-diabetic activities [77]. While
evaluating the anti-proliferative effect of pytoestrogens, it was found that Q specifically
inhibits K562 and MDR K562/A cell growth [78]. When K562 cells were treated with Q at a
Alkaloid Source of isolation IC50 value
on K562 cells



















0.2445 μM – [63]








Virosecurinine Securinega suffruticosa 32.984 μM ↑PTEN & ↓mTOR, SHIP-2
BCR-ABL, and ⊥G1/S phase
[66]
↑  upregulation, ↓  downregulation, ⊥  cell cycle arrest & *  Inhibition rate (IR) at 100 μg/ml.
Table 1. Anti-CML activity of alkaloids.
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Figure 2. List of anti-CML alkaloids as 1Ancistrotectorine E, 2Berbamine, 3BBD9, 4Camptothecin, 5BN80927,
6NSC606985, 7Homocamptothecin, 8Capsaicin, 9Cathachunine, 10Cephranathine, 11Crambescidin 800, 12
Crebanine, 13Curine, 14Cyanogramide, 159-deacetoxyfumigaclavine C, 16d-Dicentrine, 17Evodiamine, 18
Homoharringtonine, 19Naamidine J, 20Piperine, 21Salvicine, 22Staurosporine, 23UCN-01, 24Tetrandrine,
255-bromotetrandrine, 26α-tomatine, 27tylophorine, 28tylophorinine, 295-chlorosclerotiamide, 3010-
episclerotiamide, 31Eupolauramine, 32Sampangine, 33, 34, 35Arthpyrones A, B and C, 3638Auranomides A, B
and C and 39Virosecurinine.
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concentration of 9.2 mg/ml for 72 h, it induced apoptosis and reduced the BCR-ABL levels in
CML cells [79]. Combination of Q and ADR was tested on MDR K562/ADR cells. Combined
treatment enhanced activation of caspases 3,8 and loss of mitochondrial membrane potential
(MMP). Furthermore, it lowered Bcl-2, Bcl-xl and enhanced the p-c-Jun-N terminal kinase and
p-p38 mitogen-activated protein kinase (p-p38-MAPK). Q also significantly decreased the p-gp
levels [80] and sensitized MDR K562/ADM to DNR and reversed MDR in CML cells [81].
Q inhibited K562 and MDR K562/A in the range of 5160 μM. Q treatment of K562/ADR cells
(5 μM) enhanced accumulation of ADR and, in addition, decreased the expression of MDR-
causing proteins like ABC, solute carrier (SLC). Moreover, it reduced Bcl-2, TNF expression
reversing MDR in CML cells [82]. Moreover, Q arrested CML cells at G2/M phase [83]. IC50 of
Q on K562 and K562/ADR was found to be 11 ± 2 μM and 5 ± 0.4 μM [84]. It also inhibited the
Name of






























Alkaloid SCID K562 100 mg/
kg BW
Intraperitoneal ↓tumor size [52]














































Table 2. In vivo results of anti-CML NPs.
Anti-cancer Drugs - Nature, Synthesis and Cell10
Hsp70 levels in CML cells [85]. Q induced apoptosis via inhibiting the telomerase enzyme by
enhancing human telomerase reverse transcriptase (hTERT) enzymes in CML cells [86].
In sum, flavonoids not only inhibit the growth of CML cells (Table 4) but also induce their
differentiation into erythroid or monocyte lineage (Table 3). Flavonoid fractions of plant
extracts also inhibit CML cell proliferation and induced apoptosis [87109].
2.3. Terpenoids
Terpenoids are naturally occurring products representing the largest secondary metabolites.
Approximately 60% of NPs are terpenoids. They are basically made up of five carbon isoprene
units (IU). Depending upon the number of isoprene units present, terpenoids has been classi-
fied into hemiterpenoids (1 IU), monoterpenoids (2 IU), sesquiterpenoids (3 IU), diterpenoids
(4 IU), sesterterpenoids (5 IU), triterpenoids (6 IU), tetraterpenoids (8 IU) and polyterpenoid
(n IU). They have been documented to possess antioxidant, anti-inflammatory, anti-helminitic
and anti-cancer activities [110115].
Sesquiterpenoids, diterpenoids, sesterterpenoids and triterpenoidshas been shown to potently
inhibit CML cell proliferation and induce apoptosis (Figure 3) (Table 5) [116144]. Other
diterpenoids such as scapaundulin C (from Scapania undulate (L.) Dum.,) [120], parvifoline Z,
parvifoline AA (from Isodon parvifolius) [121], labdane-type diterpenes (from Chloranthus henryi
Hemsl.) [124] and sesterterpenoid compounds 3, 11 and 12 (from Sarcotragus sp.) [133] and
triterpenoid compounds 1, 2, 5, 7 and 9 (from Ganoderma hainanense) [135], (24R/S)-24-hydroxy-
Name of NP NP class Differentiation of
CML cells into
Mechanism of action References
Capsaicin Alkaloid Erythroid cells ↟GATA-1 promoter [2830]
Staurosporine Alkaloid Megakaryocytes ↟CD61, CD42b and ↓c-myc [3436]






Apigenin Flavonoid Erythroid lineage ↟ α and ϒ hemoglobin
mRNA expression
[87]
Galangin Flavonoid Monocytes ↟CD61 [90]
Genistein Flavonoid Erythroid lineage  [92]
EtOH extract of Olea
europaea
Plant extract Monocyte lineage ↟CD14 [243]
EtOH extract of Stellera
chamaejasme





Erythroid lineage ↟β-globin gene expression [272]
Table 3. List of some NPs and its differentiation capacity.
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Figure 3. Anti-CML activity of some NPs which include  flavonoids: 1Apigenin, 2Baicalein, 3Fistein, 4
Galangin, 5Genistein, 6Kaempferol, 7Myricetin, 8Naringenin, 9Nobiletin, 10Oroxylin A and 11
Tamarixetin. Terpenoids: 1Gukulenin A, 24Hebeiabinin A, D & E, 5Parvifolines C, 63-hydrogenwadaphnin, 7
Tanshinone I, 8EM23, 9, 10Felixins F & G, 11Kadlongilactone D. Polyketides: 1Epiaspinonediol, 2aza-EpoB,
3dEpoF, 4Heveadride, 5Gilvocarin HE, 6Rhizoxin, 7Salarin C, 8Tausalarin C, 9Trineurone E. Lignans: 1
Arctigenin, 2Cleistanthin A, 3Honokiol, 46-hydroxyjusticidin C, 5(+) lariciresinol 9-p-coumarate, 64-
methoxy magndialdehyde. Peptides: 1, 2chujamide A, B, 3gombamide A.
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3α 10α-epoxy-9-eip-cucurbita-25-ene (1a, b) (from Fructus Viticis Negundo) [136] are also
shown to efficiently inhibit CML cell proliferation.
2.4. Polyketides
Polyketides represent a large group of natural products that are produced by microorganisms
and plants. These are secondary metabolites, derived by the repetitive condensation of acetate
Flavonoids/flavonoid fraction IC50 value on
K562 cells
Mechanism of action References
Oroxylin A (o-methylated flavone)  ↓CXCR4, PI3K/Akt/NF-κB pathways [75, 76]
Quercetin (flavonol) 11 ± 2 µM Loss of MMP. ↑caspases 3,8 & ↓Bcl-2, Bcl-xl,
Hsp70, telomerase and ⊥G2/M phase
[7786]
Apigenin (flavone)  ↓Mcl-1, Bcl-2 & ↑caspases activation and
⊥G2/M phase
[87, 91]
Baicalein (flavone)  ↑ caspase 3, Fas gene and ⊥ S phase [88]
Fistein (flavonol)  Induced apoptosis and Altered JAK/STAT,
KIT pathways and ⊥S & G2/M phases
[89, 97]
Galangin (flavonol)  ↓pRb, cdk4, cdk1, cycline B & Bcl-2 levels and
⊥G0/G1 phase
[90]
Kaempferol (flavonol)  ↟ Bax, SIRT3, caspases 3, 9 and ↓ Bcl-2 [93]
Myricetin (flavonol)  Myricetin pre-treatment enhanced Natural
killer cells to kill K562
[96, 97]
Naringenin (flavanone)  ↟ p21/WAF1 and ⊥G0/G1 phase [98]






7.85 μg/ml ↟caspases 3, 9 & PARP cleavage [101]
2,3-Diidroochnaflavone (Luxemburgia
nobilis)





↟caspases 3, 9 and PARP cleavage [103]
Protoapigenone (total flavonoid fraction of
Macrothelypteris torresiana)
0.9 μg/ml  [104]
Total flavonoids from Lysimachia clethroides
Duby (ZE4)
 ↓Bcl-2 and ↑Fas, TRAIL & DR5 [105]
Total flavonoids of Astragali Radix 98.63 mg/L ↓ cyclin D1 mRNA levels and ⊥G0/G1 phase [106]
Total oligomer flavonoids of Rhamnus
alaternus
196 μg/ml  [107]





Epigallocatechin-3-gallate (Camellia sinensis) 50 μM ↓CyclinD1, CDC25A and ↑TGF-β2 [109]
Table 4. Anti-CML activity of flavonoids.
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Sesquiterpenoids EM23 Elephantopus mollis 10.8 μM ↟ caspases, PARP
cleavage and
↓ NFκB. Loss of
MMP
[116]
Diterpenoids Caesalminaxin D and H Caesalpinia minax 9.9 ± 1.7 and
9.2 ± 0.9 μM
 [117]
Gukulenin A and diterpenoid
pseudodimers (25)
Phorbas gukhulensis *0.26 ± 0.03,
0.12 ± 0.01,
0.44 ± 0.01,
0.32 ± 0.05 and
0.04 ± 0.09 μM
 [118]
Diterpene compounds 11, 12,
13, 14 and 15
petroleum ether
soluble fraction of









Isodon xerophilus 0.04 μM  [122]













Rabdocoetsin B and D
Isodon enanderianus 0.130.87 μg/
ml
 [127]
Ludongnin J Isodon rubescens
var. lushiensis
0.18 μg/ml  [128]
Tanshinone I Salvia miltiorrhiza
Bunge.




16, 17 and 20
Isodon nervosus 2.39, 4.11, 1.05
and 1.55 μM
[130]
5-Episinuleptolideacetate Sinularia species 4.09 μg/ml ↓c-ABL, Akt,
NFκB
[144]
Sesterterpenoids Felixins F and G Ircinia felix 1.27 and 19.9
μM
 [131]
















4.15 μM  [138]
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units or other short carboxylic acids catalyzed by multi-functional enzymes called polyketide
synthases (PKSs) which is similar to fatty acid synthases [145]. Many polyketides suppress
CML cell proliferation and induce apoptosis (Figure 3) (Table 6) [146155].
2.5. Lignans
Lignans, natural compounds that are exclusively found in plants, are derived from amino acid
phenyl alanine. They possess anti-oxidant and anti-cancer activities [156]. Various lignans
effectively inhibit CML cell proliferation and induced apoptosis (Figure 3) (Table 6) [157163].
2.6. Saponins
Saponins are a diverse group of secondary metabolites widely distributed in the plant king-
dom. They produce soap-like foam when shaken in aqueous solutions. Their structure com-
prise of triterpene or steroid aglycone and one or more sugar chains. They exhibit anti-cancer
and anti-cholesterol activities [164, 165]. Various saponins inhibited CML cell proliferation
(Table 6) [166174].
2.7. Peptides
Two peptides, chujamides A (1) and B (2), isolated from the marine sponge Suberites waedoensis
inhibited K562 cell growth with LC50 values of 37 and 55.6 μM [175]. Another peptide,
gombamide A (1), isolated from the marine sponge Clathria gombawuiensis inhibited CML
cell proliferation with LC50 of 6.9 μM [176]. Haishengsu (HSS), a protein extract from








>100 μM  [139]
Kadlongilactone D Kadsura
longipedunculata
1.92 μM  [140]
Six triterpenes fractions of
Aceriphyllum rossii
methanolic extract

















Table 5. Anti-CML activity of terpenoids.
Natural Products for Treatment of Chronic Myeloid Leukemia
http://dx.doi.org/10.5772/66175
15
Type of NP Name of compound Source of isolation IC50 value
on K562
Mechanism of action References











Gilvocarin HE Streptomyces sp.
QD012




 ↓p-Raf1, p-BCR-ABL [151]
Rhizoxin Burkholderia rhizoxina 5×10−7 μg/
ml
 [152]
Salarin C Fascaplysinopis sp. 0.1 μM ↟ caspase 3 and 9
cleavage
[153]
Tausalarin C Fascaplysinopis sp. 1 μM  [154]
Trineurone E Peperomia trineura 26 μM  [155]
Lignans Arctigenin Asteraceae family  ↑Bax and ↓ Bcl-2 [157]
Cleistanthin A Cleistanthus collinus
(Rox B)
0.4 μM  [158]
5,5-Dimethoxylariciresinol-4-
O-β-D-glucoside (DMAG)
Mahonia  ↓IC50 of DOX from




28.4 μM  [160]





(+)-Lariciresinol 9-p-coumarate Larix olgensis var.
koreana.
2.9 μg/ml  [162]
4-Methoxy magndialdehyde Magnolia officinalis 3.9 μg/ml  [163]
Saponins Astrgorgiosides A, B, C (19-





Wattoside G, H, and I (steroidal
saponins)






Marsdenia tenacissima 31.4 μM ↓ cyclin D, Bcl-2, Bcl-
xL and ↑caspases 3, 9,
Bax and Bak
[170]




6.72 μM  [171]
Total saponin content Aralia Taibaiensis  Loss of MMP. ↑ Bax
and ↓ Bcl-2
[172]
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Tegillarca granosa,when administered in mice-bearing MDR K562/ADM cell tumors inhibited
tumor growth and downregulated mdr1 gene, BCR-ABL and sorcin [177]. HSS was also
tested against MDR K562/ADR cells, and it induced apoptosis at 20 mg/l [178]. HSS also
inhibited K562 cells at G0/G1 and S phase and lowered Bcl-2 and enhanced Bax levels
(Figure 2) (Table 6) [179].
2.8. Others natural products
Other natural products such as acetylenic metabolites, betanin, bufadienolide, mamea a/ba,
cryptotanshinone, bavachalcone, polyanthumin, cubebin, denbinobin, digallic acid, perforanoid
A, β- and α-mangostin, parthenolide, perezone, polyphyllin D, squamocin, toxicarioside H,
tripolide, woodfordin I and rhodexin A inhibited CML cell proliferation (Table 7) [180230].
Moreover, many plant crude extracts enriched with NPs inhibited the CML cell proliferation and
induced apoptosis (Table 8) [231280].
2.9. Natural products in clinical trials
Of the several natural products, Homoharringtonine (alkaloid) (NCT00114959) is currently
under phase II study sponsored by Chem Genex pharmaceuticals to reverse the Gleevac resis-
tance in CML patients [281]. 17-AAG (analogue of glendamycinpolyketide) (NCT00100997) is
currently under phase I clinical trial sponsored by Jonsson Comprehensive Cancer Center collab-
orated with National Cancer Institute (NCI). Efforts are underway to determine the side effects
and optimal dose of 17-AAG for treating patients with CML in chronic phase who did not
respond to imatinib-mesylate [282]. Paclitaxel (diterpenoid) (NCT00003230) is currently under
Phase I/II trials to study the effectiveness in treating patients with refractory or recurrent acute
leukemia or CML. This work is sponsored by Swiss Group for Clinical Cancer Research [283].
Type of NP Name of compound Source of isolation IC50 value
on K562
Mechanism of action References




↑ Bax and ↓ Bcl-2,
PCNA
[173]
23-Hydroxybetulinic acid Total saponin content
of Pulsatilla chinensis
(Bunge) Regel
 ↟ Bax, caspase 3
cleavage and ↓ Bcl-2,
survivin
[174]
Peptides Chujamides A and B Suberites waedoensis *37 and
55.6 μM
 [175]
Gombamide A Clathria gombawuiensis *6.9 μM  [176]
*LC50lethal concentation.
Table 6. Anti-CML activities of polyketides, lignans, saponins and peptides.
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Name of NP Source of isolation IC50 value on
K562 cells
Mechanism of action References
Acetylenic metabolites Stelletta sp. 43.5, 51.3 and
62.5 μg/ml
 [180]
Betanin (betacyanin pigment) Opuntia ficus-indica 40 μM ↟ PARP cleavage, release of













26.5 ± 2.12 and
23.49 ± 1.85 μg/
ml
 [184]






Angelica dahurica 8.614.6 μg/ml  [186]
Mamea A/BA Calophyllum
brasiliense
0.040.59 μM  [187, 188]
Cryptotanshinone (lipid soluble
active compound)
Salvia miltiorrhiza  induced apoptosis ↑ PARP
cleavage and ↓BCR-ABL,
STAT3, mTOR & eIF4E
[189, 190]












1.84 μM ↓ BCR-ABL, CrkL and⊥G2/M
phase
[194]
Digallic acid Pistascia lentiscus  Induced DNA fragmentation











C27-Steroidal glycoside Liriope graminifolia
(Linn.) Baker
18.6 μg/ml  [198]
9α-Acetoxyartecanin, apressin,
inducumenone and centaureidin
Achillea clavennae 9.84 ± 2.52, 4.44
± 0.76, 52.53 ±
8.43 and
5.37 ± 0.8 μM
 [199]
Perforanoid A (limonoid) – 4.24 μM  [200]
Linoleic acid Methanol extracts
of proso and
Japanese millet
68 μM  [201]
β- and α-Mangostin Garcinia malaccensis  [202, 203]
Anti-cancer Drugs - Nature, Synthesis and Cell18
Name of NP Source of isolation IC50 value on
K562 cells









20.7 and 36 μg/
ml
 [204]
Parthenolide  17.1, 8.67 and
9.42 for 24, 48
and 72 h
Induced apoptosis [205]
Perezone Perezia spp.  Cytotoxic to CML cells at 25,





Coniothyrium cereal 8.5 μM  [207]
Polyphyllin D Paris polyphyllin  ↟ p21, Bax, caspase 3 & Cyt. C
release and ↓ cyclin B1, cdk1,
Bcl-2. Loss of MMP and ⊥ G2/
M phase
[208]
Polysaccharide (PSP001) Punica granatum 52.8 ± 0.9 μg/ml  [209]




06 μg/ml  [210]
Highly methoxylated bibenzyls Frullania inouei 11.349.6 μM  [211]
Sarcovagine and β-sitosterol 5- 8 Sarcococca saligna 2.55 μM  [212]
Squamocin (annonaceous
acetogenins)
–  ↟ cdk inhibitors, p21, p27 & ↓
cdk1, cdk25c and ⊥G2/M
phase
[213]






* 2.2, 1.9, 3.9,
4.6, 3.9 and 3.6
μM
 [215]
ar-Turmerone Curcuma longa L 2050 μg/ml Induced DNA fragmentation
and apoptosis
[216]
Terpene metabolites (13) Clathria
gombawuiensis
*4.7, 3.9 and 2.1
μM
 [217]
Toxicarioside H (nor-cardenolide) Antiaris toxicaria
(Pers.) Lesch
0.037 μg/ml  [218]
Tripolide Chinese herbal
extract











0.15 ± 0.02 and
0.65 ± 0.01 μM
 [220]
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Name of NP Source of isolation IC50 value on
K562 cells
Mechanism of action References









  ↓ Bcl-2, Bcl-xL, Bax, c-Abl &
BCR-ABL and Loss of MMP
[222]
Gaudichaudic acid, isogambogenic




0.41 ± 0.03, 2.1 ±
0.14 and 1.74 ±
0.22 μg/ml
 [223]
Xindongnins CD, A, B,




0.37.3 μg/ml  [224]





Rhodexin A Rhodea japonica 19 nM ⊥G2/M phase induced
apoptosis
[226]
Curcumin Curcumina longa 20 μg/ml ↓BCR-ABL, Hsp90, WT1 [227, 228]




Table 7. Anti-CML activity of other natural products.
Plant extract IC50 value on K562 cells Mechanism of action References
Acetone extract of Peucedanum
nebrodense (Guss.) Strohl.,
1410.27 μg/ml  [231]
AQE extract of Cornus officinalis
Sieb. et Zuce
100 μg/ml  [232]
AQE extracts of the husk fiber of
the typical A and common varieties
of Cocos nucifera (Palmae)
At 500 μg/ml the cell viability
of CML cells was found to be
60.1 ± 8.5 and 47.5 ± 11.9%
 [233]
AQE extract of Rhodiola imbricate  ↓CML cell proliferation at 100 and
200 μg/ml for 72 hrs. induced ROS &
apoptosis and ⊥G2/M phase
[234]
Abnobaviscum F® (standardized
AQE extract of European mistletoe
from the host tree Fraxinus)
 ↟ caspase 9, JNK-1,2, p38 MAPK and
↓ Bcl-1, Erk-1/2 & PKB
phosphorylation
[235]
Chloroform extract of Polyalthia
rumphii stem
4060μ/ml  [236]
Chloroform extract of Tecomella
undulata bark
30 μg/ml ↟ FAS, FADD, & caspase 8, 3/7.
Induced DNA fragmentation &
apoptosis
[237]
DCM) extract of Psidium guajava L. 32 μg/ml  [238]
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Plant extract IC50 value on K562 cells Mechanism of action References
DCM extract Artemisia turanica
Krasch
69 μg/ml ↟ caspases, PARP cleavage. Induced
DNA damage and apoptosis
[239]
HEX and DCM extract ofMesua
beccariana
*20 ± 1.5 and 43.75 ± 0.78 μg/ml  [240]
HEX and DCM extract ofMesua
ferrea
*17.5 ± 1.02 and 22.91 ± 1.25 μg/
ml
 [240]
HEX extract ofMesua congestiflora 40.63 ± 1.45 μg/ml  [240]
DCM fraction ofMelissa officinalis At 50 μg/ml concentration, it
induced 65.04 ± 0.93%
apoptotic rate
↟ Fas, Bax mRNA levels and Bax/Bcl-
2 ratio
[241]
DCM fraction of the crude EtOH
extract of Echinops grijissi Hance
roots
30 μg/ml  [242]
EtOH extract of Pereskia sacharosa 130 ± 0.03 μg/ml ↟ caspases, cyt. C release, p21 & p53
and ↓Akt and Bcl-2
[244]
EtOH extract of propolis (NP
produced by stingless beeMelipona
orbignyi)
At 250 and 500 μg/ml
promoted cell death of CML
cells by 15 ± 1 and 63 ± 2%
 [245]
EtOH extract of Isodon japonicas 2.7 μg/ml  [246]
EtOH root extract of Allamanda
schottii
At 800 μg/ml showed
cytotoxicity
 [247]
EtOH stem and leaf extract of
Physalis peruviana
0.02 and 0.03 g/ml  [248]
Alcoholic extract of Dendrostellera
lessertii
28 μl and 5 × 10−9M  [249]
EtOH extract of Rosmarinus
officinalis L
1/400 dilution  [251]
EtOH extract of Goldfussia
psilostachys
0.5 μg/ml ↟ CML cells in G2/M phase [252]
Fraction from EtoAc of Caesalpinia
spinosa
44.5 ± 4.05 μg/ml induced chromatin condensation.
Loss of MMP & ↑ caspase 3
[253]
EtoAc extract of Helichrysum
plicatum flowers
25.9 μg/ml  [254]
MeOH extract of Linum persicum 0.1 μg/ml  [255]
MeOH extracts of Echinophora
cinerea and Cirsium bracteosum
Less than 20 μg/ml  [256]
MeOH extract of Galium mite 39.8 μg/ml  [256]
MeOH extract of Cyperus rotundus 175 ± 1.2 μg/ml Induced DNA damage [257]
TAF273, F3 and F4 fractions of
MeOH extract of Eurycoma
longifolia Jack
19, 55 and 62 μg/ml  [258]
MeOH extract of Rhaphidophora
korthalsii
 Enhanced Natural killer cells to kill
K562, ↟IFN-ϒ, TNF-α
[259]




CML is a hematological malignancy that arises due to chromosomal translocation resulting in the
presence of Ph chromosome. Initially, TKIs were designed to compete with the ATP binding site
Plant extract IC50 value on K562 cells Mechanism of action References
MeOH extract of Rhinella jimi
Stevaux (Anura: Bufonidae) skin
*235 μg/ml  [260]
MeOH extract of Hypericum
perforatum L.flower extract
 Induced apoptosis [261]
HEX, DCM, EtoAc, butanol and
MeOH extracts of Helichrysum
zivojinii Černjavski and Soška
11.78 ± 0.94, 23.82 ± 6.54, 27.52 ±
4.96, 50.37 ± 3.28 and 74.88 ±
7.57 μg/ml (for 72 h)
 [262]
Acetate: MeOH (95:5), acetate,
chloroform and HEX fractions of
Erythroxylum caatingae plowman
13.1 ± 0.63, 9.86 ± 0.56, 11.21 ±
0.46, 33.58 ± 1.33 μg/ml
 [263]
DCM extract of Arctium lappa root ^17 μg/ml  [264]
Alisma orientalis (Sam) Juzep extract  Reverse of MDR [265]
Polyphenolic extract of Ichnocarpus
fructescens leaves
 At 5, 10, 20 μg/ml con. ↓K562 cell
proliferation
[266]
EtOH extract of Orbignya speciosa 33.9 ± 4.3 μg/ml  [267]
Coptis chinensis and Epimedium
sagittatum extracts
29 and74 μg/ml  [268]
Sangre de Drago is red viscous
latex extract of Croton lechleri
2.5 ± 0.3 μg/ml  [269]
Dionysia termeana extract 20 μg/ml  [270]
Ganoderma lucidum extract *50 μg/ml  [271]
Crude MeOH extracts of Luehea
candicans Mart. et Zucc. branches
and leaves
#8.15.4 μg/ml  [273]
Nerium oleander extract  ↓p-gp [274]
Ponicidin (Rabdosia rubescens
extract)
 ↓ Bcl-2 and ↑ Bax, caspase 3 & PARP
cleavage
[276]
Scutellaria litwinowii Bornm. and
Sint. ex Bornm.
 ↟ caspase 3,8, PARP cleavage, Bax/
Bcl-2 ratio
[278]
Swietenia mahagoni leaf extract  ↟ caspases 3,9, Cyt. C release and
⊥G2-M phase
[279]
Viscin, (lipophilic extract from
Viscum album L)
252 ± 37 μg/ml  [280]
AQE, aqueous, DCM, dichloromethane, HEX, hexane, EtOH, ethanol, EtoAc, ethyl acetate, MeOH, methanol, ^TGI,
tumor growth inhibition,*ED50, effective concentration; # GI50, growth inhibition.
Table 8. Anti-CML activity of plant extracts.
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of BCR-ABL. TKIs effectively inhibited wild-type BCR-ABL; however, mutations in BCR-ABL
and overexpression of drug efflux proteins following treatment decreased their potency.
Since, there is a need for alternative strategy to develop new BCR-ABL inhibitors; NPs
(obtaining from living organisms) offers an alternate, effective and inexpensive design for
CML therapy. Moreover, they have less (or) no side effects. Studies conducted so far have
revealed that many NPs inhibit CML cell proliferation and, in addition, induce cell death
through apoptosis. NPs alone or in combination with other TKIs are able to reverse the MDR,
thereby increasing the sensitivity of TKIs towards CML. Moreover, many NPs are able to
differentiate CML cells into erythroid, monocyte or macrophage lineage. In vivo results have
clearly shown that NPs potently suppress tumor growth. In sum, NPs serve as an inexhaust-
ible source which renders an attractive alternate strategy to combat CML.
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Ph Philadelphia chromosome
MAPK mitogen activated protein kinase
STAT signal transducers and activator of transcription
PI3K phosphoinositide 3-kinase
TKIs tyrosine kinase inhibitor
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MDR multi drug resistance
p-gp p-glycoprotein
NPs natural products
NCEs new chemical entities
BBM berbamine
K562/IR imatinib resistant K562 cell line
cyt. C cytochrome C
BW body weight
ADR adriamycin
Hsp90 heat shock protein 90
BBD9 4-chlorobenzoyl berbamine
PARP Poly(ADP-Ribose) polymerase
LC3 II LC3-phosphatidylethanolamine conjugate
DOX doxorubicin
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